Dralle H, Lorenz K, Nguyen-Thanh P
Zentrum für Chirurgie I, Martin Luther University, Halle, Germany.
Langenbecks Arch Surg. 1999 Dec;384(6):556-62. doi: 10.1007/s004230050243.
The valid operative standard for primary hyperparathyroidism (pHPT) consists of cervicotomy and presentation of all parathyroid glands. This operative technique features the macroscopic identification of the responsible adenoma. It also has the advantage of detecting multiglandular disease. The increasing sensitivity of preoperative localization methods and the possibility of intra-operative measurement of parathyroid hormone prepared the way for minimally invasive procedures.
All patients with pHPT were examined by cervical sonography and sestamibi scintigraphy of the parathyroid glands. Patients eligible for the described procedure had to comply to the following inclusion criteria: biochemical evidence of pHPT, localization of one unequivocally enlarged parathyroid gland on two corresponding imaging results; no former surgery or radiation to the neck; no multinodular goiter; no suspected carcinoma of the thyroid; and no secondary or recurrent hyperparathyroidism. We used an operative technique first described by Miccoli in 1997. Before preparation and at 2, 10 and 15 min after exstirpation of the parathyroid adenoma, peripheral blood was drawn. The operation was terminated when a 50% decrease of preoperative PTH levels was reached.
During a 12-month period (1 December 1997 to 30 November 1998), 13 patients with pHPT of a total of 59 patients (22%) with hyperparathyroidism (pHPT and sHPT) were operated on employing this minimally invasive procedure. In three patients, the operative technique had to be converted to the conventional procedure due to superior adenomas in two cases and a dorsoesophageal adenoma in one case. The procedure could thus be successfully completed in ten patients. The overall failure rate was zero in all patients with regard to the underlying disease. There was one temporary, recurrent laryngeal-nerve palsy. The mean overall length of the hospital stay was 3 days.
The minimally invasive video-assisted parathyroidectomy for localized single-gland adenoma is a new and attractive surgical therapy option for primary hyperparathyroidism due to improved patient comfort, shortened length of hospital stay and favorable cosmetic results. This may lead to one-day surgery and, therefore, to a reduction of overall costs.
原发性甲状旁腺功能亢进症(pHPT)的有效手术标准包括颈部切开术及所有甲状旁腺的显露。该手术技术以肉眼识别责任腺瘤为特点,还具有能检测多腺体疾病的优势。术前定位方法敏感性的提高以及术中测量甲状旁腺激素的可能性为微创操作铺平了道路。
所有pHPT患者均接受甲状旁腺颈部超声检查和锝[99mTc]甲氧基异丁基异腈(sestamibi)闪烁扫描。符合所述手术的患者必须符合以下纳入标准:pHPT的生化证据,两种相应影像学检查结果显示一个明确增大的甲状旁腺;既往无颈部手术或放疗史;无结节性甲状腺肿;无甲状腺癌可疑;无继发性或复发性甲状旁腺功能亢进症。我们采用了1997年Miccoli首次描述的手术技术。在准备甲状旁腺腺瘤切除术前以及切除后2、10和15分钟采集外周血。当术前甲状旁腺激素(PTH)水平下降50%时手术结束。
在12个月期间(1997年12月1日至1998年11月30日),59例甲状旁腺功能亢进症(pHPT和继发性甲状旁腺功能亢进症[sHPT])患者中有13例(22%)采用这种微创方法进行了手术。3例患者因2例为上位腺瘤和1例为背侧食管腺瘤,手术技术不得不转为传统手术。因此,该手术在10例患者中成功完成。所有患者潜在疾病的总体失败率为零。有1例暂时性喉返神经麻痹。平均住院总时长为3天。
对于局限性单腺体腺瘤的微创电视辅助甲状旁腺切除术,因其能提高患者舒适度、缩短住院时间并获得良好的美容效果,是原发性甲状旁腺功能亢进症一种新的且有吸引力的手术治疗选择。这可能导致日间手术,从而降低总体费用。